Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
34,723,329
-
Total 13F shares
-
12,196,527
-
Share change
-
+2,072,762
-
Total reported value
-
$463,251,136
-
Price per share
-
$38.16
-
Number of holders
-
50
-
Value change
-
+$92,385,423
-
Number of buys
-
37
-
Number of sells
-
14
Institutional Holders of IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) as of Q4 2019
As of 31 Dec 2019,
IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,196,527 shares.
The largest 10 holders included
Redmile Group, LLC, BAKER BROS. ADVISORS LP, JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, L.P., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, HILLHOUSE CAPITAL ADVISORS, LTD., BlackRock Inc., Cormorant Asset Management, LP, and Artal Group S.A..
This page lists
50
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.